Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Page 81 of 100 Appendix B to Part 40 - DOT Drug Testing Semi-Annual Laboratory Report to Employers The following items are required on each report: Reporting Period: (inclusive dates) Laboratory Identification: (name and address) Employer Identification: (name; may include Billing Code or ID code) C/TPA Identification: (where applicable; name and address) 1. Specimen Results Reported (total number) By Type of Test (a) Pre-employment (number) (b) Post-Accident (number) (c) Random (number) (d) Reasonable Suspicion/Cause (number) (e) Return-to-Duty (number) (f) Follow-up (number) (g) Type of Test Not Noted on CCF (number) 2. Specimens Reported (a) Negative (number) (b) Negative and Dilute (number) 3. Specimens Reported as Rejected for Testing (total number) By Reason (a) Fatal flaw (number) (b) Uncorrected Flaw (number) 4. Specimens Reported as Positive (total number) By Drug (a) Marijuana Metabolite (number) (b) Cocaine Metabolite (number) (c) Opiates (number) (1) Codeine (number) (2) Morphine (number) (3) 6-AM (number) (d) Phencyclidine (number) (e) Amphetamines (number) (1) Amphetamine (number) (2) Methamphetamine (number) 5. Adulterated (number) 6. Substituted (number) 7. Invalid Result (number) [65 FR 79526, Dec. 19, 2000, as amended 73 FR 35975, June 25, 2008]
Appendix C to Part 40-DOT Drug Testing Semi-Annual Laboratory Report to DOT Mail, fax, or email to: U.S. Department of Transportation Office of Drug and Alcohol Policy and Compliance W62-300 1200 New Jersey Avenue, S.E. Washington, DC 20590 Fax: (202) 366-3897 Email: ODAPCWebMail@dot.gov The following items are required on each report: Reporting Period: (inclusive dates) Laboratory Identification: (name and address) 1. DOT Specimen Results Reported (number) 2. Negative Results Reported (number) 3. Rejected for Testing Reported (number) By Reason (number) 4. Positive Results Reported (number) By Drug (number) 5. Adulterated Results Reported (number) By Reason (number) 6. Substituted Results Reported (number) 7. Invalid Results Reported (number) By Reason (number) [73 FR 35975, June 25, 2008] Page 82 of 100
- Page 403 and 404: Page 30 of 100 (a) Review Copy 2 of
- Page 405 and 406: Page 32 of 100 (1) As the DER, you
- Page 407 and 408: Page 34 of 100 (i) Recent needle tr
- Page 409 and 410: Page 36 of 100 (2) If you receive i
- Page 411 and 412: Page 38 of 100 (iii) If a negative
- Page 413 and 414: Page 40 of 100 (6) Result of the te
- Page 415 and 416: Page 42 of 100 (d) When you receive
- Page 417 and 418: Page 44 of 100 (1) Report that the
- Page 419 and 420: Page 46 of 100 (2) There is not an
- Page 421 and 422: Page 48 of 100 (c) The laboratory r
- Page 423 and 424: Page 50 of 100 (6) The failure to d
- Page 425 and 426: Page 52 of 100 partially meets thes
- Page 427 and 428: Page 54 of 100 (c) As the user of t
- Page 429 and 430: Page 56 of 100 (vi) You must then d
- Page 431 and 432: Page 58 of 100 (i) You may transmit
- Page 433 and 434: Page 60 of 100 (b) In the case of a
- Page 435 and 436: Page 62 of 100 (iii) Key DOT drug t
- Page 437 and 438: Page 64 of 100 § 40.295 May employ
- Page 439 and 440: Page 66 of 100 (e) The requirements
- Page 441 and 442: Page 68 of 100 accident drug test r
- Page 443 and 444: Page 70 of 100 § 40.343 What tasks
- Page 445 and 446: Page 72 of 100 and follow-up testin
- Page 447 and 448: Page 74 of 100 (b) In exercising th
- Page 449 and 450: Page 76 of 100 resubmit the matter
- Page 451 and 452: Page 78 of 100 § 40.397 When does
- Page 453: Appendix A to Part 40 - DOT Standar
- Page 457 and 458: Page 84 of 100 Appendix E to Part 4
- Page 459 and 460: Appendix G to Part 40—Alcohol Tes
- Page 461 and 462: Page 88 of 100
- Page 463 and 464: Page 90 of 100
- Page 465 and 466: I. Employer: Company Name: Page 92
- Page 467 and 468: Page 94 of 100 The following form a
- Page 469 and 470: Section III. Drug Testing Data Page
- Page 471 and 472: Page 98 of 100 TIP ~ Even though so
- Page 473 and 474: Page 100 of 100 Finally, additional
- Page 475 and 476: 43946 Federal Register / Vol. 68, N
- Page 477 and 478: 43948 Federal Register / Vol. 68, N
- Page 479 and 480: 43950 Federal Register / Vol. 68, N
- Page 481 and 482: 43952 Federal Register / Vol. 68, N
- Page 483 and 484: 43954 Federal Register / Vol. 68, N
- Page 485 and 486: 43956 Federal Register / Vol. 68, N
- Page 487 and 488: 43958 Federal Register / Vol. 68, N
- Page 489 and 490: 43960 Federal Register / Vol. 68, N
- Page 491 and 492: 43962 Federal Register / Vol. 68, N
- Page 493 and 494: 43964 Federal Register / Vol. 68, N
- Page 495 and 496: Federal Register / Vol. 68, No. 250
- Page 497 and 498: Federal Register / Vol. 68, No. 250
- Page 499 and 500: Federal Register / Vol. 68, No. 250
- Page 501 and 502: Federal Register / Vol. 68, No. 250
- Page 503 and 504: Federal Register / Vol. 68, No. 250
Page 81 of 100<br />
Appendix B to Part 40 - DOT Drug Testing Semi-Annual Laboratory Report to Employers<br />
The following items are required on each report:<br />
Reporting Period: (inclusive dates)<br />
Laboratory Identification: (name and address)<br />
Employer Identification: (name; may include Billing Code or ID code)<br />
C/TPA Identification: (where applicable; name and address)<br />
1. Specimen Results Reported (total number)<br />
By Type of Test<br />
(a) Pre-employment (number)<br />
(b) Post-Accident (number)<br />
(c) Random (number)<br />
(d) Reasonable Suspicion/Cause (number)<br />
(e) Return-to-Duty (number)<br />
(f) Follow-up (number)<br />
(g) Type of Test Not Noted on CCF (number)<br />
2. Specimens Reported<br />
(a) Negative (number)<br />
(b) Negative and Dilute (number)<br />
3. Specimens Reported as Rejected for Testing (total number)<br />
By Reason<br />
(a) Fatal flaw (number)<br />
(b) Uncorrected Flaw (number)<br />
4. Specimens Reported as Positive (total number) By Drug<br />
(a) Marijuana Metabolite (number)<br />
(b) Cocaine Metabolite (number)<br />
(c) Opiates (number)<br />
(1) Codeine (number)<br />
(2) Morphine (number)<br />
(3) 6-AM (number)<br />
(d) Phencyclidine (number)<br />
(e) Amphetamines (number)<br />
(1) Amphetamine (number)<br />
(2) Methamphetamine (number)<br />
5. Adulterated (number)<br />
6. Substituted (number)<br />
7. Invalid Result (number)<br />
[65 FR 79526, Dec. 19, 2000, as amended 73 FR 35975, June 25, 2008]